Verastem reported $-21.3M in EBITDA for its fiscal quarter ending in September of 2023.





Ebitda Change Date
AbbVie USD 5.37B 1.85B Dec/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
AstraZeneca USD 5.67B 1.29B Mar/2026
Curis USD -12.3M 231K Sep/2023
Cytokinetics USD -169.32M 19.48M Mar/2026
Gilead Sciences USD 3.02B 1.01B Dec/2025
Incyte USD 367.97M 46.53M Mar/2026
Laboratory Of America USD 605.6M 17.5M Mar/2026
Novartis USD 5.3B 530M Mar/2026
Pfizer USD 5.99B 5.23B Mar/2026
Roche Holding CHF 12.68B 2.36B Jun/2024
TG Therapeutics USD 51.69M 19M Dec/2025